Overview

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Status:
Completed
Trial end date:
2019-07-27
Target enrollment:
Participant gender:
Summary
The aim of this research is to better understand how patient-level factors can be used to predict the appropriate enoxaparin dose to maximize venous thromboembolism (VTE) risk reduction and minimize bleeding.
Phase:
Phase 2
Details
Lead Sponsor:
University of Utah
Collaborator:
University of Michigan
Treatments:
Dalteparin
Enoxaparin
Enoxaparin sodium
Heparin, Low-Molecular-Weight